Sentence examples for development of potentials to from inspiring English sources
By suitable derivations it was possible to fit the development of potentials to the Avrami equation.
Findings inform the development of potential solutions to these challenges which may be tested further empirically.
These findings provide insight into the demographics of concern about vaccine safety and inform the development of potential interventions to improve knowledge about HBV vaccination.
Therefore, the understanding of innate-like lymphocytes may be crucial for the development of potential therapies to restore immune system function in patients with sepsis.
This finding is reassuring in view of potential to development of resistance.
In this chapter, we are discussing briefly more than 100 lead structures to access information about the active and inhibition fingerprints toward the development of potential drug candidate to deal the unanswered diseases.
Clearly, more specific ABCG2 inhibitors are needed for future development of potential chemo-sensitizers to better treat drug resistant cancers.
Development of an improved and more selective CFTR corrector that transforms into clinical studies would facilitate the development of potential new therapies to treat the severe physiological outcomes associated with the ΔF508 CFTR mutation.
Biopharmaceutical companies were also less likely or able to fund the advanced development of potential countermeasures themselves, unwilling to take the considerable financial risk that their products would fail in development or not be procured by BioShield even if the products were successful.
Typically, there are several goals to be achieved in the development of potential biomarkers by glycoproteomics: 1) to identify the glycosylated-proteins, their glycosylation sites, and the glycan compositions; 2) to quantify the glycosylated-proteins and their glycosylation extent; 3) to validate the potential glycosylated-protein biomarkers; and 4) to establish the clinical test method.
LB-152 provides a new lead for further development of potential β-amyloid aggregation inhibitors to treat AD.
